Sarah A. Teichmann, Director at 10x Genomics, sold TXG on Aug 14, 2026
Data as of Oct 16
- Traded
- Aug 14, 2026
- Disclosed
- Aug 17, 2026
- Filed
- 3 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
TXG since disclosure
+20.5%
after the sale
Similar stocks (XLV) since disclosure
+5.8%
XLV — its sector index fund
Change in closing price from Aug 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLSarah A. Teichmann DirectorTXG 10x Genomics, Inc.$302Kdisclosed Aug 17 · filed 4 days after the trade